These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12472127)

  • 1. Multimodality therapy for esophageal cancer.
    Refaely Y; Krasna MJ
    Surg Clin North Am; 2002 Aug; 82(4):729-46. PubMed ID: 12472127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined-modality therapy for locoregional esophageal cancer].
    Kim SB
    Korean J Gastroenterol; 2004 Oct; 44(4):179-85. PubMed ID: 15505428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
    Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
    Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of multimodality therapy for esophageal cancer.
    Krasna MJ; Tepper J
    Chest Surg Clin N Am; 2000 Aug; 10(3):591-603. PubMed ID: 10967760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
    Swisher SG; Maish M; Erasmus JJ; Correa AM; Ajani JA; Bresalier R; Komaki R; Macapinlac H; Munden RF; Putnam JB; Rice D; Smythe WR; Vaporciyan AA; Walsh GL; Wu TT; Roth JA
    Ann Thorac Surg; 2004 Oct; 78(4):1152-60; discussion 1152-60. PubMed ID: 15464463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does neoadjuvant chemoradiation downstage esophageal carcinoma?
    Slater MS; Holland J; Faigel DO; Sheppard BC; Deveney CW
    Am J Surg; 2001 May; 181(5):440-4. PubMed ID: 11448438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
    Mortensen MB
    Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative chemotherapy for resectable thoracic esophageal cancer.
    Malthaner R; Fenlon D
    Cochrane Database Syst Rev; 2001; (1):CD001556. PubMed ID: 11279723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinoma.
    Hashimoto J; Kato K; Ito Y; Kojima T; Akimoto T; Daiko H; Hamamoto Y; Matsushita H; Katano S; Hara H; Tanaka Y; Saito Y; Nagashima K; Igaki H
    Int J Clin Oncol; 2019 Jan; 24(1):60-67. PubMed ID: 30109544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the clinical staging for esophageal carcinoma after preoperative chemoradiation therapy].
    Fu JH; Wang G; Yang H; Hu Y; Wen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jan; 12(1):12-6. PubMed ID: 19145495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thoracoscopic staging and surgical therapy for esophageal cancer.
    Sugarbaker DJ; Jaklitsch MT; Liptay MJ
    Chest; 1995 Jun; 107(6 Suppl):218S-223S. PubMed ID: 7781397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Staging and neoadjuvant therapy of squamous cell carcinoma of esophagus].
    Benhidjeb T; Moesta KT; Schlag PM
    Ther Umsch; 2001 Mar; 58(3):165-73. PubMed ID: 11305155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant therapy for esophageal cancer: surgical considerations.
    Piraino A; Vita ML; Tessitore A; Cusumano G; Congedo MT; Margaritora S; Porziella V; Meacci E; Cesario A; Granone P
    Rays; 2006; 31(1):37-45. PubMed ID: 16999374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma.
    Rizk NP; Venkatraman E; Bains MS; Park B; Flores R; Tang L; Ilson DH; Minsky BD; Rusch VW;
    J Clin Oncol; 2007 Feb; 25(5):507-12. PubMed ID: 17290058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidisciplinary approach to esophageal and gastric cancer.
    Stein HJ; Sendler A; Fink U; Siewert JR
    Surg Clin North Am; 2000 Apr; 80(2):659-82; discussions 683-6. PubMed ID: 10836011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical staging and surgical treatment in esophageal cancer.
    Krasna MJ
    Semin Oncol; 1999 Oct; 26(5 Suppl 15):9-11. PubMed ID: 10566605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined modality treatment in oesophageal carcinoma.
    Maughan TS; Crosby TD
    Clin Oncol (R Coll Radiol); 1998; 10(6):354-5. PubMed ID: 9890534
    [No Abstract]   [Full Text] [Related]  

  • 18. [Multimodality therapy concepts in esophageal carcinoma].
    Siewert JR; Ott K
    Kongressbd Dtsch Ges Chir Kongr; 2001; 118():39-43. PubMed ID: 11824282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Esophageal carcinoma: non-surgical therapy].
    Geissler M; Schwacha H; Eggstein S; Usadel H; Harder J; Opitz O; Arnold C; Grimm CF; Blum HE
    Praxis (Bern 1994); 2004 Dec; 93(49):2057-64. PubMed ID: 15630988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncologic Outcomes According to Remnant Lymph Node Metastases in Pathologic T0 (ypT0) Esophageal Squamous Cell Carcinoma Following Prospective Neoadjuvant Therapy and Surgery.
    Cho HJ; Kim YH; Kim HR; Kim DK; Park SI; Kim JH; Kim SB
    Ann Surg Oncol; 2015; 22(6):1851-7. PubMed ID: 25344308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.